Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 5, 2008
Adenovirus MART-1-engineered autologous dendritic cell vaccine for metastatic melanomaLisa H Butterfield, Begonya Comin-Anduix, Lazar Vujanovic, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 2, 2009
Intratumoral immune cell infiltrates, FoxP3, and indoleamine 2,3-dioxygenase in patients with melanoma undergoing CTLA4 blockadeAntoni Ribas, Begoña Comin-Anduix, James S Economou, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 13, 2003
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanomaLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.Cancer Discovery|March 23, 2013
Multifunctional T-cell analyses to study response and progression in adoptive cell transfer immunotherapyChao Ma, Ann F Cheung, Thinle Chodon, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|February 6, 2013
Allelic exclusion and peripheral reconstitution by TCR transgenic T cells arising from transduced human hematopoietic stem/progenitor cellsFrancesca Giannoni, Cinnamon L Hardee, Jennifer Wherley, et al.Cancer Immunology, Immunotherapy : CII|September 1, 2005
Broad antitumor protection by dendritic cells administered to CD8alpha knock out miceAntoni Ribas, Dan D Vo, David L Weeks, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|August 18, 2004
Role of dendritic cell phenotype, determinant spreading, and negative costimulatory blockade in dendritic cell-based melanoma immunotherapyAntoni Ribas, John A Glaspy, Yohan Lee, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 6, 2006
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four alpha-fetoprotein peptidesLisa H Butterfield, Antoni Ribas, Vivian B Dissette, et al.The Journal of Investigative Dermatology|August 19, 2011
Immunomodulation by imiquimod in patients with high-risk primary melanomaRupa Narayan, Hong Nguyen, Jason J Bentow, et al.Journal of Translational Medicine|May 3, 2008
Detailed analysis of immunologic effects of the cytotoxic T lymphocyte-associated antigen 4-blocking monoclonal antibody tremelimumab in peripheral blood of patients with melanomaBegoña Comin-Anduix, Yohan Lee, Jason Jalil, et al.Pageof 5